Search results for "Pulmonary fibrosi"

showing 10 items of 96 documents

Lung microenvironments and disease progression in fibrotic hypersensitivity pneumonitis

2022

Rationale: Fibrotic hypersensitivity pneumonitis (fHP) is an interstitial lung disease caused by sensitization to an inhaled allergen. Objectives: To identify the molecular determinants associated with progression of fibrosis. Methods: Nine fHP explant lungs and six unused donor lungs (as controls) were systematically sampled (4 samples/lung). According to microcomputed tomography measures, fHP cores were clustered into mild, moderate, and severe fibrosis groups. Gene expression profiles were assessed using weighted gene co-expression network analysis, xCell, gene ontology, and structure enrichment analysis. Gene expression of the prevailing molecular traits was also compared with idiopathi…

AdultGenetic MarkersMalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyExtrinsic Allergic Alveolitisextrinsic allergic alveolitisCritical Care and Intensive Care MedicineSeverity of Illness IndexTranscriptome03 medical and health sciences0302 clinical medicineFibrosisPulmonary fibrosisMedicineHumansLungAged030304 developmental biology0303 health sciencesLungmedicine.diagnostic_testpulmonary fibrosisbusiness.industryGene Expression ProfilingInterstitial lung diseaseReproducibility of ResultsOriginal ArticlesMiddle Agedrespiratory systemmedicine.diseaseFibrosisIdiopathic Pulmonary Fibrosis3. Good healthrespiratory tract diseasesmedicine.anatomical_structureBronchoalveolar lavage030228 respiratory systemCase-Control StudiesDisease ProgressionLinear ModelsFemaleHuman medicineTranscriptomebusinesstranscriptomeHypersensitivity pneumonitisAlveolitis Extrinsic AllergicAmerican journal of respiratory and critical care medicine
researchProduct

Patients Suffering from a Chronic, Irreversible Illness: A Novel Study on the Psychological Intervention out of the Hospital

2020

Objective: Patients with chronic, untreatable diseases have emotional needs that are often unaddressed by conventional care services within the healthcare systems. The situation of patients with idiopathic pulmonary fibrosis (IPF) is paradigmatic as there are few, if any, studies focusing on psychological interventions for these patients. This chapter describes a study that identifies and quantifies emotional distress, quality of life, spirituality, and key dimensions of health-related well-being after brief psychotherapy treatments at an outpatient clinic.

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentPsychological interventionmedicine.diseaseBrief psychotherapyIdiopathic pulmonary fibrosisQuality of life (healthcare)Emotional distressSpiritualitymedicineOutpatient clinicPsychiatrybusinessHealthcare system
researchProduct

In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats

2003

1. This study examines the activity of the antioxidant N-acetylcysteine on bleomycin-induced pulmonary fibrosis in rats with emphasis on the early inflammatory phase. 2. Rats receiving N-acetylcysteine (300 mg kg(-1) day(-1), intraperitoneal) had less augmented lung wet weight, and lower levels of proteins, lactate dehydrogenase, neutrophil and macrophage counts in bronchoalveolar lavage fluid and lung myeloperoxidase activity with a betterment of histological score at 3 days postbleomycin. 3. A diminished lung GSH/GSSG ratio and augmented lipid hydroperoxides were observed 3 days postbleomycin. These changes were attenuated by N-acetylcysteine. Alveolar macrophages from bleomycin-exposed r…

PharmacologyPathologymedicine.medical_specialtyNecrosisLungmedicine.diagnostic_testbusiness.industrySuperoxiderespiratory systemmedicine.diseaseBleomycinrespiratory tract diseasesNitric oxideDrug vehiclechemistry.chemical_compoundBronchoalveolar lavageEndocrinologymedicine.anatomical_structurechemistryInternal medicinePulmonary fibrosismedicinemedicine.symptombusinessBritish Journal of Pharmacology
researchProduct

Optimising experimental research in respiratory diseases: an ERS statement

2018

Experimental models are critical for the understanding of lung health and disease and are indispensable for drug development. However, the pathogenetic and clinical relevance of the models is often unclear. Further, the use of animals in biomedical research is controversial from an ethical perspective.The objective of this task force was to issue a statement with research recommendations about lung disease models by facilitating in-depth discussions between respiratory scientists, and to provide an overview of the literature on the available models. Focus was put on their specific benefits and limitations. This will result in more efficient use of resources and greater reduction in the numb…

Animal Experimentation0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialtyBiomedical ResearchStatement (logic)Advisory CommitteeseducationMEDLINEDiseaseLung injury[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractHIGHLAND WHITE TERRIERSACUTE LUNG INJURY03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicineINBRED MOUSE STRAINSPulmonary fibrosisAnimalsHumansMedicineIntensive care medicineSocieties MedicalALLERGIC AIRWAY INFLAMMATIONbusiness.industryCOMMUNITY-ACQUIRED PNEUMONIACIGARETTE-SMOKE EXPOSURERespiration Disordersmedicine.diseaseDISTRESS-SYNDROME3. Good healthEuropeDisease Models Animal030104 developmental biologyANIMAL-MODELS030228 respiratory systemDrug developmentData qualityARTERIAL-HYPERTENSIONIDIOPATHIC PULMONARY-FIBROSISbusiness
researchProduct

Role of MUC4 in idiopathic pulmonary fibrosis

2019

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible form of fibrotic intersticial lung disease, characterized by uncontrolled fibroblast proliferative processes and alveolar type II epithelial dysfunction. MUC4, a multi-domain transmembrane glycoprotein, is often overexpressed in epithelial cancers, with consequences for the biological properties, involved in cellular processes related to IPF. However, the role of MUC4 in IPF has not beet studied yet. Objective: To analyze the implication of MUC4 in IPF Methods: Lung tissue from 14 healthy and 14 IPF patients was obtained. MUC4 expression was analyzed by western blot, RT-PCR and immunohistochemistry. T…

0301 basic medicineA549 cellLungbusiness.industryReceptor expression05 social sciencesrespiratory systemmedicine.diseaserespiratory tract diseases03 medical and health sciencesIdiopathic pulmonary fibrosis030104 developmental biologymedicine.anatomical_structure0502 economics and businessmedicineCancer researchImmunohistochemistry050211 marketingsense organsEpithelial–mesenchymal transitionFibroblastbusinessMyofibroblastIdiopathic interstitial pneumonias
researchProduct

Strategies targeting fibrosis in pulmonary disease

2006

Pulmonary fibrosis is potentially a curable disease, but this potential is dependent on correct identification of disease targets at the research stage. While invaluable work has been done in animal models to identify factors involved in the initiation of fibrogenesis, we must now shift our focus towards identifying factors involved in the chronic progression of fibrosis and how to modulate the progressive nature of the disease towards repair or regeneration of non-functioning pulmonary tissue.

PharmacologyPathologymedicine.medical_specialtybusiness.industryRegeneration (biology)Pulmonary diseaseDiseasemedicine.diseaseBioinformaticsFibrosisDrug DiscoveryPulmonary fibrosismedicineMolecular MedicinebusinessDrug Discovery Today: Therapeutic Strategies
researchProduct

Psychological Profile of Patients Diagnosed With Idiopathic Pulmonary Fibrosis

2022

Pulmonary and Respiratory Medicinemedicine.medical_specialtyIdiopathic pulmonary fibrosisbusiness.industryInternal medicineMEDLINEmedicinemedicine.diseasebusinessArchivos de Bronconeumología
researchProduct

Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.

2008

ABSTRACT We report the isolation of thymidine-dependent small-colony variants (TD-SCVs) of Staphylococcus aureus from unusual infection sites of patients with chronic soft tissue infection, tympanitis, bronchitis, peritonitis, and septicemia. Furthermore, we provide evidence that the essential growth factor for TD-SCVs, i.e., thymidine, and its metabolite dTMP are present in various human specimens.

Microbiology (medical)AdultMaleStaphylococcus aureusPancreatic diseaseCystic FibrosisPeritonitisPeritonitismedicine.disease_causeCystic fibrosischemistry.chemical_compoundSepsisPulmonary fibrosismedicineHumansBronchitisChildbusiness.industryRespiratory diseaseBacteriologyPneumoniaMiddle AgedStaphylococcal Infectionsmedicine.diseasechemistryStaphylococcus aureusImmunologyBronchitisFemalebusinessThymidineThymidineJournal of clinical microbiology
researchProduct

Role of IL-11 in vascular function of pulmonary fibrosis patients

2019

Pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) portends a poor prognosis. Currently, no therapy can improve survival of patients diagnosed with this disease. IL-11 molecular pathway is over-expressed in proliferative disorders, however, its role in PH- associated IPF is unknown. The aim of this study was to evaluated the expression of IL-11 in IPF patients with or without PH. Also we hypothesized that the stimulation of pulmonary artery smooth muscle cells (PASMCs) and human pulmonary artery microvascular endothelial cells (HMVEC-L) with IL-11 induced the transformation into invasive myofibroblast. Human pulmonary artery rings, parenchyma tissue, broncho-alveolar lavage …

Pathologymedicine.medical_specialtybusiness.industryStimulationrespiratory systemmedicine.diseasePulmonary hypertensionrespiratory tract diseases03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicine030228 respiratory systemmedicine.arteryPulmonary arteryParenchymaPulmonary fibrosismedicineDistribution (pharmacology)030212 general & internal medicinebusinessMyofibroblastPulmonary hypertension
researchProduct

The small heat-shock protein α B-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis

2014

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by the proliferation of myofibroblasts and the accumulation of extracellular matrix (ECM) in the lungs. TGF-β1 is the major profibrotic cytokine involved in IPF and is responsible for myofibroblast proliferation and differentiation and ECM synthesis. αB-crystallin is constitutively expressed in the lungs and is inducible by stress, acts as a chaperone and is known to play a role in cell cytoskeleton architecture homeostasis. The role of αB-crystallin in fibrogenesis remains unknown. The principal signalling pathway involved in this process is the Smad-dependent pathway. We demonstrate here that αB-crystallin is stron…

Biologymedicine.diseaseHedgehog signaling pathwayPathology and Forensic MedicineCell biologyExtracellular matrixIdiopathic pulmonary fibrosisFibrosisHeat shock proteinPulmonary fibrosisImmunologymedicinesense organsNuclear export signalMyofibroblastThe Journal of Pathology
researchProduct